FORTE Study Updates (October 2025)

October 14 2025

Remote Consent & Mobile Phlebotomy

FORTE leadership encourages sites to examine implementing remote consenting in your site’s patient enrollment processes. Since NRG-CC005 does not require an in-person visit to enroll, FORTE sites currently consent patients using platforms such as RedCap, DocuSign, and snail mail. The highest accruing sites have remote components for enrollment, stool collection, and blood sample collection. Additionally, patients have expressed enjoying the ease of enrolling into FORTE using remote processes like RedCap.

Many institutions have re-examined policies around remote research in the past few years to accommodate changing patient expectations. If you have any questions about implementing remote consent processes for FORTE at your site, contact forte@nrgoncology.org.

Whether your site chooses to implement remote consent or continues accruing participants in person, NRG Oncology is working with TravaLab, an online portal that offers mobile phlebotomy services nationwide, to conduct blood draws for FORTE.

No additional contracting or payment is required for sites to use this service, but you must opt-in for the service by notifying NRG Oncology. Opting in does not obligate you to use the service. Review the revised NRG-CC005 funding sheet on CTSU for payment information with TravaLab.

The FORTE team has created the FORTE TravaLab Manual - Mobile Phlebotomy to guide sites on implementing mobile phlebotomy. Review this document on CTSU to determine if your site may partner with TravaLab to offer this service to your participants.

To get started with TravaLab, fill out the TravaLab Registration Form on CTSU and submit it to forte@nrgoncology.org.


Accrual Updates and Milestones (as of October 1, 2025)

Top accruing sites:

Kaiser Permanente – Vallejo – 1754 accrued

UPMC-Presbyterian Hospital – 337 accrued

Regions Hospital – 147 accrued

Most recent randomizations:

Providence Veterans Administration Hospital – October 1, 2025

Kaiser Permanente-Anaheim – September 30, 2025

Kaiser Permanente-Vallejo – September 30, 2025

Kaiser Permanente-Irvine – September 30, 2025

Kaiser Permanente-Ontario – September 30, 2025

UCHealth University of Colorado Hospital – September 30, 2025

Bay Pines VA Healthcare System – September 30, 2025

Essentia Health Saint Joseph's Medical Center – September 30, 2025 


FORTE Top 25 Accruing Sites – October 1, 2025

Picture1-5.png


FORTE Resource Portal

Bookmark this website, that organizes materials found on CTSU: https://www.nrgoncology.org/Clinical-Trials/NRG-CC005/FORTE-Resource-Portal. You will use the same login information as for CTSU to access this page. Once you gain access, the “FORTE Materials for Research Professionals” section contains many materials to assist you with accruing participants. This website also has contact information for questions you may have while working on NRG-CC005.

Find both CIRB-approved and protocol-related documents on CTSU under NRG-CC005.

Do you have new research team members working on NRG-CC005?

Clinical research professionals can sign up for NRG Weekly Broadcasts to receive FORTE Fridays updates directly to your inbox: https://www.nrgoncology.org/Home/News/Weekly-Broadcasts.  

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:   

FORTE@NRGOncology.org

1 (800) 477-7227

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.